Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tanvex BioPharma Inc
Cost of Revenue Peer Comparison

Comparables:
688235
6550

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Cost of Revenue
-NT$26.2m
CAGR 3-Years
-451%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Cost of Revenue
-ÂĄ2.7B
CAGR 3-Years
-77%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Cost of Revenue
-NT$10.5m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Cost of Revenue?
Cost of Revenue
-26.2m TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Cost of Revenue amounts to -26.2m TWD.

What is Tanvex BioPharma Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-451%

Over the last year, the Cost of Revenue growth was -88%. The average annual Cost of Revenue growth rates for Tanvex BioPharma Inc have been -451% over the past three years .

Back to Top